11 Results

People

  1. Asgari
    Asgari
  2. De Stanchina
    De Stanchina
  3. Younes
    Younes
  4. Seshan
    Seshan
  5. Da Silva Ferreira
    Da Silva Ferreira
  6. Erazo Andrade
    Erazo Andrade
  7. Mondello
    Mondello
  8. Cadete Portelinha
    Cadete Portelinha
  9. Derenzini
    Derenzini
  10. Hendrickson
    Hendrickson

Groups

  1. Center for Hematologic Malignancies (11)
  2. Department of Medicine (11)
  3. Executive Committee, Center for Hematologic Malignancies (10)
  4. Hematologic Malignancies, Division of (10)
  5. Lymphoma (10)
  6. Sloan Kettering Institute Postdocs (10)
  7. Biostatistics Service (9)
  8. Epidemiology and Biostatistics (9)
  9. Center for Pancreatic Cancer Research (8)
  10. GSK Faculty (7)
  1. "Zahra Asgari"
Formats
  1. Journal Article (7)
  2. Meeting Abstract (4)
Groups
  1. Center for Hematologic Malignancies (11)
  2. Department of Medicine (11)
  3. Executive Committee, Center for Hematologic Malignancies (10)
  4. Hematologic Malignancies, Division of (10)
  5. Lymphoma (10)
  6. Sloan Kettering Institute Postdocs (10)

More Groups

People
  1. Zahra Asgari (11)
  2. Anas Younes (10)
  3. Elisa De Stanchina (10)
  4. Venkatraman Seshan (8)
  5. Ingrid Erazo Andrade (5)
  6. Mariana Da Silva Ferreira (5)

More People

Years
  1. 2023 (1)
  2. 2022 (2)
  3. 2021 (1)
  4. 2019 (1)
  5. 2018 (2)
  6. 2017 (1)

More Years

Publications
  1. Blood (3)
  2. Nature Communications (2)
  3. Cancer Research (1)
  4. Cell Reports (1)
  5. Cell Reports Medicine (1)
  6. Clinical Cancer Research (1)

More Publications

Publishers
  1. American Society of Hematology (3)
  2. American Association for Cancer Research (2)
  3. Cell Press (2)
  4. Nature Publishing Group (2)
  5. Impact Journals (1)
  6. National Academy of Sciences (1)

Results (11)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Synthetic lethality of drug-induced polyploidy and BCL-2 inhibition in lymphoma
    Journal Article

    Portelinha, A.; da Silva Ferreira, M.; Erazo, T.; Jiang, M.; Asgari, Z.; de Stanchina, E.; Younes, A.; Wendel, H. G.
    Nature Communications (2023)

    Fulltext@MSK | Save
  • Pharmacologically induced polyploidy triggers BCL2 dependence in lymphomas
    Meeting Abstract

    Portelinha, A.; da Silva Ferreira, M.; Erazo, T.; Asgari, Z.; de Stanchina, E.; Younes, A.; Wendel, H. G.
    Cancer Research (2022)

    Fulltext@MSK | Save
  • TP53 mutations and RNA-binding protein MUSASHI-2 drive resistance to PRMT5-targeted therapy in B-cell lymphoma
    Journal Article

    Erazo, T.; Evans, C. M.; Zakheim, D.; Chu, K. L.; Refermat, A. Y.; Asgari, Z.; Yang, X.; Da Silva Ferreira, M.; Mehta, S.; Russo, M. V.; more...
    Nature Communications (2022)

    Fulltext@MSK | Save
  • ASN007 is a selective ERK1/2 inhibitor with preferential activity against RAS-and RAF-mutant tumors
    Journal Article

    Portelinha, A.; Thompson, S.; Smith, R. A.; Da Silva Ferreira, M.; Asgari, Z.; Knezevic, A.; Seshan, V.; de Stanchina, E.; Gupta, S.; Denis, L.; more...
    Cell Reports Medicine (2021)

    Fulltext@MSK | Save
  • Dual inhibition of MCL1 and BCL2 in lymphoma using tumor targeted nanoparticles
    Meeting Abstract

    Bala, N. B.; Taghizadeh Manzari, M.; Da Silva Ferreira, M.; Asgari, Z.; Hagen, C.; Seshan, V.; de Stanchina, E.; Manova-Todorova, K.; Heller, D.; Younes, A.
    Blood (2019)

    Fulltext@MSK | Save
  • NOXA genetic amplification or pharmacologic induction primes lymphoma cells to BCL2 inhibitor-induced cell death
    Journal Article

    Liu, Y.; Mondello, P.; Erazo, T.; Tannan, N. B.; Asgari, Z.; de Stanchina, E.; Nanjangud, G.; Seshan, V. E.; Wang, S.; Wendel, H. G.; more...
    Proceedings of the National Academy of Sciences of the United States of America (2018)

    Fulltext@MSK | Save
  • BET inhibition-induced GSK3β feedback enhances lymphoma vulnerability to PI3K inhibitors
    Journal Article

    Derenzini, E.; Mondello, P.; Erazo, T.; Portelinha, A.; Liu, Y.; Scallion, M.; Asgari, Z.; Philip, J.; Hilden, P.; Valli, D.; more...
    Cell Reports (2018)

    Fulltext@MSK | Save
  • Dual inhibition of histone deacetylases and phosphoinositide 3-kinase enhances therapeutic activity against B cell lymphoma
    Journal Article

    Mondello, P.; Derenzini, E.; Asgari, Z.; Philip, J.; Brea, E. J.; Seshan, V.; Hendrickson, R. C.; de Stanchina, E.; Scheinberg, D. A.; Younes, A.
    Oncotarget (2017)

    Fulltext@MSK | Save
  • Dual inhibition of histone deacetylases and phosphoinositide 3-kinase enhances therapeutic activity against B cell lymphoma
    Meeting Abstract

    Mondello, P.; Derenzini, E.; Asgari, Z.; Philip, J.; Brea, E. J.; Seshan, V. E.; Hendrickson, R.; de Stanchina, E.; Scheinberg, D. A.; Younes, A.
    Blood (2016)

    Fulltext@MSK | Save
  • MYC-dependent PI3K and MCL-1 feedbacks attenuate BET inhibitors activity in diffuse large B-cell lymphoma
    Meeting Abstract

    Derenzini, E.; Mondello, P.; Liu, Y.; Scallion, M.; Asgari, Z.; Philip, J.; Hilden, P.; Djaballah, H.; Ouerfelli, O.; de Stanchina, E.; more...
    Blood (2016)

    Fulltext@MSK | Save